Administration of interleukin-17 soluble receptor c suppresses T H17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy

Hypertension

Volumn 62, Issue 6, 2013, Pages 1068-1073

  Cornelius, Denise C ^a   Hogg, James P ^b   Scott, Jeremy ^a   Wallace, Kedra ^b   Herse, Florian ^c   Moseley, Janae ^a   Wallukat, Gerd ^c   Dechend, Ralf ^c   La Marca, Babbette ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Hypertension; Inflammation; Oxidative stress; Pregnancy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; INTERLEUKIN 17 RECEPTOR; ISOPROSTANE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 17 RECEPTOR C; SUPEROXIDE; UNCLASSIFIED DRUG; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETER; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELLULAR IMMUNODEFICIENCY; DRUG INFUSION; FEMALE; GESTATIONAL AGE; ISCHEMIA; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC PUMP; OXIDATIVE STRESS; PERFUSION; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRESSURE; PRIORITY JOURNAL; RAT; TH17 CELL; URINE LEVEL; UTERINE ARTERY; WEIGHT REDUCTION; ANIMAL; DRUG EFFECT; HYPERTENSION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PLACENTA; SPRAGUE DAWLEY RAT; VASCULARIZATION; COMPLICATION; DRUG EFFECTS;

HYPERTENSION; INFLAMMATION; OXIDATIVE STRESS; PREGNANCY;

ANIMALS; FEMALE; HYPERTENSION; INTERLEUKIN-17; ISCHEMIA; OXIDATIVE STRESS; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, INTERLEUKIN-17; TH17 CELLS;

EID: 84891617036     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01514     Document Type: Article

References (23)

1. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol. 2005;1:98-114; quiz 120.
2. George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol. 2010;5:557-566.
3. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372.
4. Lindheimer MD, Romero R. Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia. Hypertension. 2007;50:35-36.
5. Lamarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 2010;62:105-120.
6. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183:7023-7030.
7. Wallace K, Richards S, Dhillon P, Weimer A, Edholm ES, Bengten E, Wilson M, Martin JN Jr, LaMarca B. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension. 2011;57:949-955.
8. Mai J, Wang H, Yang XF. Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci (Landmark Ed). 2010;15:986-1006.
9. Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol. 2011;32:603-611.
10. Toldi G, Rigó J Jr, Stenczer B, Vásárhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol. 2011;66:223-229.
11. Granger J P, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 2001;14(6 Pt 2):178S-185S.
12. Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Mosely J, Martin JN Jr, Dechend R, LaMarca B. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2012;303:R353-R358.
13. Kuestner RE, Taft DW, Haran A, et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol. 2007;179:5462-5473.
14. LaMarca B, Wallace K, Herse F, Wallukat G, Martin JN Jr, Weimer A, Dechend R. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension. 2011;57:865-871.
15. Parrish MR, Wallace K, Tam Tam KB, Herse F, Weimer A, Wenzel K, Wallukat G, Ray LF, Arany M, Cockrell K, Martin JN, Dechend R, LaMarca B. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens. 2011;24:835-840.
16. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT (1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-2387.
17. Dechend R, Homuth V, Wallukat G, Müller DN, Krause M, Dudenhausen J, Haller H, Luft FC. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig. 2006;13:79-86.
18. LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, Wallukat G, Wenzel K, Cockrell K, Martin JN Jr, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 2009;54:905-909.
19. Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, Keiser S, Ray LF, Dechend R, Martin JN, Granger JP, LaMarca B. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens. 2010;23:911-916.
20. Parrish MR, Ryan MJ, Glover P, Brewer J, Ray L, Dechend R, Martin JN Jr, Lamarca BB. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend Med. 2011;8:184-188.
21. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens. 2007;20:686-691.
22. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during mycobacterium tuberculosis infection. J Immunol. 2006;177:4662-4669.
23. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol. 2003;170:2106-2112.